Dronabinol, 2.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Medicare coverage: Special coverage instructions apply
Status: active (July 2026 file)
MUE: max 0 units per day (practitioner), rationale: Oral Medication; Not Payable